MedTech Dive April 3, 2023
For decades, researchers and diabetes patients have been working to develop an artificial pancreas with the ability to detect blood sugar levels and administer insulin as needed. Those efforts have led to the commercialization of the first hybrid closed-loop systems —where continuous glucose monitors and insulin pumps work in tandem — in the multibillion-dollar market for diabetes devices.
These systems still come with some limitations. For one, patients can’t choose which devices they want to pair together as the software that lets the two devices work together currently is integrated into insulin pumps.
So as companies including Medtronic, Dexcom and Tandem Diabetes Care worked to build their own connected devices, people with diabetes and family members started grassroots...
Today's Sponsors
Today's Sponsor